Childrens’ Pain Reliever Recalled Due to Potentially Higher Potency Level

Tris Pharma announced a voluntary nationwide recall of 3 lots of Infants’ Ibuprofen Concentrated Oral Suspension, 50mg/1.25mL as the products may contain higher concentrations of ibuprofen.

Ingesting nonsteroidal anti-inflammatory drugs (NSAID) at a higher potency level may cause nausea, vomiting, epigastric pain, diarrhea, tinnitus, headache, and even gastrointestinal bleeding; pediatric patients are also at greater risk of developing NSAID-associated renal injury.  

The recalled products were sold at Walmart stores, CVS Pharmacy, and Family Dollar Services. The specific lots include:

Equate: Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID), 50mg/1.25mL, 0.5oz bottle

• Lot# 00717009A (Exp 02/19)
• Lot# 00717015A (Exp 04/19)
• Lot# 00717024A (Exp 08/19)

CVS Health: Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID), 50mg/1.25mL, 0.5oz bottle

• Lot# 00717024A (Exp 08/19) 

Family Wellness: Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID), 50mg/1.25mL, 0.5oz bottle

• Lot# 00717024A (Exp 08/19) 

To date, no reports of adverse events related to the recall have been reported. 

For more information call (732) 940-0358 or visit TrisPharma.com.

Follow @ClinicalPainAdv

This article originally appeared on MPR